Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company that is focused on the research, development and commercialization of oncology and antiviral drugs. The Company’s drug development operations include SBFM-PL4 Anti-Coronavirus Treatment and Adva-27a Anticancer Drug. The Company’s drug development activities are focused on the development of a small molecule called Adva-27a for the treatment of aggressive forms of cancer. A Topoisomerase II inhibitor, Adva-27a has been shown to be effective at destroying Multidrug Resistant Cancer cells, including pancreatic cancer cells, breast cancer cells, small-cell lung cancer cells and uterine sarcoma cells. The Company, through its subsidiary, Sunshine Biopharma Canada Inc. (Sunshine Canada), develops science-based nutritional supplements. Its product includes Essential 9 a nutritional supplement tablets, which is comprised of the nine essential amino acids for human body.